Edition:
United Kingdom

Recro Pharma Inc (REPH.OQ)

REPH.OQ on NASDAQ Stock Exchange Capital Market

11.72USD
18 May 2018
Change (% chg)

$0.69 (+6.26%)
Prev Close
$11.03
Open
$11.07
Day's High
$11.80
Day's Low
$11.07
Volume
67,980
Avg. Vol
54,674
52-wk High
$12.41
52-wk Low
$5.85

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Wayne Weisman

60 2008 Independent Chairman of the Board

Geraldine Henwood

61 2008 President, Chief Executive Officer, Director

Ryan Lake

40 2018 Chief Financial Officer

Michael Celano

58 2018 Chief Operating Officer

Jyrki Mattila

62 2017 Executive Vice President - Business Development